Balance Sheet Data
Meridian Bioscience, Inc. (VIVO)
$25.77
-0.30 (-1.15%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 57.07 | 59.76 | 62.40 | 53.51 | 49.77 | 89.23 | 100.84 | 113.95 | 128.77 | 145.51 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 29.11 | 32.34 | 35.61 | 38.51 | 53.57 | 57.03 | 64.45 | 72.83 | 82.30 | 93 |
| Account Receivables (%) | ||||||||||
| Inventories | 41.49 | 41.99 | 39.62 | 61.26 | 76.84 | 77.85 | 87.98 | 99.42 | 112.34 | 126.95 |
| Inventories (%) | ||||||||||
| Accounts Payable | 7.72 | 6.26 | 7.24 | 11.97 | 11.70 | 13.49 | 15.24 | 17.23 | 19.47 | 22 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -4.47 | -4.20 | -3.80 | -3.30 | -18.31 | -9.44 | -10.67 | -12.06 | -13.62 | -15.40 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.